AYI Stock Analysis: Acuity | NYSE
Electrical Equipment & Parts | NYSE, USA | Market Cap: 9.482m USD | 12M Return: -12.4% | US00508Y1029 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 112M
EPS Trend: 98.3%
Qual. Beats: 1
Rev. Trend: 93.7%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Acuity Inc. (NYSE: AYI) is an Atlanta-headquartered industrial company that designs and manufactures lighting, lighting controls, building management systems, and audio/video/control platforms for customers in the United States and abroad. It operates through two segments: Acuity Brands Lighting (ABL), which sells luminaires and lighting components under a large portfolio of proprietary brands (such as Lithonia Lighting, Juno, Gotham, and Holophane) to electrical distributors, retailers, and OEM customers; and Acuity Intelligent Spaces (AIS), which delivers connected building management and AV solutions under the Atrius, Distech Controls, QSC, and KE2 Therm Solutions brands to venues including retail stores, airports, universities, enterprise campuses, sports venues, and hospitality properties. The company was incorporated in 2001 and changed its name from Acuity Brands, Inc. to Acuity Inc. in March 2025.
Classified within the GICS Industrials sector under Electrical Components & Equipment, Acuity generates roughly $9.3 billion in market capitalization as a mid-cap issuer, and its business model centers on selling engineered, branded lighting fixtures and integrated building systems through distribution and system-installer channels rather than competing as a low-cost commodity supplier.
- Non-residential construction slowdown pressures ABL lighting demand
- AIS segment margins expand on QSC audio platform integration
- LED pricing competition from imports compresses lighting margins
| Net Income: 531.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 4.14 > 1.0 |
| NWC/Revenue: 16.42% < 20% (prev 18.54%; Δ -2.12% < -1%) |
| CFO/TA 0.17 > 3% & CFO 825.6m > Net Income 531.3m |
| Net Debt (168.1m) to EBITDA (893.8m): 0.19 < 3 |
| Current Ratio: 1.69 > 1.5 & < 3 |
| Outstanding Shares: last quarter (30.8m) vs 12m ago -2.47% < -2% |
| Gross Margin: 50.64% > 18% (prev 47.83%; Δ 2.81% > 0.5%) |
| Asset Turnover: 96.42% > 50% (prev 91.39%; Δ 5.03% > 0%) |
| Interest Coverage Ratio: 25.08 > 6 (EBIT TTM 737.4m / Interest Expense TTM 29.4m) |
| A: 0.16 (Total Current Assets 1.86b - Total Current Liabilities 1.10b) / Total Assets 4.87b |
| B: 0.95 (Retained Earnings 4.63b / Total Assets 4.87b) |
| C: 0.15 (EBIT TTM 737.4m / Avg Total Assets 4.81b) |
| D: 1.57 (Book Value of Equity 2.97b / Total Liabilities 1.90b) |
| Altman-Z'' = 6.79 = AAA |
| DSRI: 1.00 (Receivables 632.1m/593.9m, Revenue 4.64b/4.35b) |
| GMI: 0.94 (GM 47.83% / 50.64%) |
| AQI: 0.97 (AQ_t 0.55 / AQ_t-1 0.56) |
| SGI: 1.07 (Revenue 4.64b / 4.35b) |
| TATA: -0.06 (NI 531.3m - CFO 825.6m) / TA 4.87b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of October 29, 2026, the stock is trading at USD 317.08 with a total of 426,100 shares traded. Over the past week, the price has changed by +0.10%, over one month by +3.72%, over three months by -7.81% and over the past year by -12.42%.
Current recommended Stop Loss: 305.10 (which is 3.8% or 1.3 ATR below the current price).
Acuity has received a consensus analysts rating of 3.57. Therefore, it is recommended to hold AYI.
- StrongBuy: 1
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 370.2 | 16.7% |
P/E Trailing = 18.2465
P/E Forward = 14.1044
P/S = 2.0428
P/B = 3.2131
P/EG = 1.2104
Revenue TTM = 4.64b USD
EBIT TTM = 737.4m USD
EBITDA TTM = 893.8m USD
Long Term Debt = 697.3m USD (from longTermDebt, two quarters ago)
Short Term Debt = 200.0m USD (from shortTermDebt, last quarter)
Debt = 804.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 107.0m
Net Debt = 168.1m USD (calculated: Debt 804.4m - CCE 636.3m)
Enterprise Value = 9.65b USD (9.48b + Debt 804.4m - CCE 636.3m)
Interest Coverage Ratio = 25.08 (Ebit TTM 737.4m / Interest Expense TTM 29.4m)
EV/FCF = 12.90x (Enterprise Value 9.65b / FCF TTM 747.9m)
FCF Yield = 7.75% (FCF TTM 747.9m / Enterprise Value 9.65b)
FCF Margin = 16.11% (FCF TTM 747.9m / Revenue TTM 4.64b)
Net Margin = 11.45% (Net Income TTM 531.3m / Revenue TTM 4.64b)
Gross Margin = 50.64% ((Revenue TTM 4.64b - Cost of Revenue TTM 2.29b) / Revenue TTM)
Gross Margin QoQ = 53.85% (prev 50.62%)
Tobins Q-Ratio = 1.98 (Enterprise Value 9.65b / Total Assets 4.87b)
Interest Expense / Debt = 3.65% (Interest Expense 29.4m / Debt 804.4m)
Taxrate = 21.95% (149.4m / 680.7m)
NOPAT = 575.6m (EBIT 737.4m * (1 - 21.95%))
Current Ratio = 1.69 (Total Current Assets 1.86b / Total Current Liabilities 1.10b)
Debt / Equity = 0.27 (Debt 804.4m / totalStockholderEquity, last quarter 2.97b)
Debt / EBITDA = 0.19 (Net Debt 168.1m / EBITDA 893.8m)
Debt / FCF = 0.22 (Net Debt 168.1m / FCF TTM 747.9m)
Total Stockholder Equity = 2.87b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.04% (Net Income 531.3m / Total Assets 4.87b)
RoE = 18.54% (Net Income TTM 531.3m / Total Stockholder Equity 2.87b)
RoCE = 20.70% (EBIT 737.4m / Capital Employed (Equity 2.87b + L.T.Debt 697.3m))
RoIC = 15.37% (NOPAT 575.6m / Invested Capital 3.74b)
WACC = 10.60% (E(9.48b)/V(10.3b) * Re(11.26%) + D(804.4m)/V(10.3b) * Rd(3.65%) * (1-Tc(0.22)))
Discount Rate = 11.26% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -73.63 | Cagr: -1.03%
[DCF] Terminal Value 71.04% ; FCFF base≈661.9m ; Y1≈758.8m ; Y5≈1.12b
[DCF] Fair Price = 395.7 (EV 12.0b - Net Debt 168.1m = Equity 11.8b / Shares 29.9m; r=10.60% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.25 | EPS CAGR: 12.44% | SUE: 1.43 | # QB: 1
Revenue Correlation: 93.67 | Revenue CAGR: 8.88% | SUE: -0.04 | # QB: 0
EPS current Quarter (2026-11-30): EPS=5.09 | Chg30d=-0.07% | Revisions=-12% | Analysts=6
EPS next Quarter (2027-02-28): EPS=4.43 | Chg30d=-3.35% | Revisions=-62% | Analysts=6
EPS current Year (2027-08-31): EPS=21.31 | Chg30d=-1.76% | Revisions=-44% | GrowthEPS=+7.1% | GrowthRev=+3.9%
EPS next Year (2028-08-31): EPS=23.27 | Chg30d=-2.41% | Revisions=-44% | GrowthEPS=+9.2% | GrowthRev=+5.0%
[Analyst] Revisions Ratio: -56% (up=4, down=18)